| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2098487-52-4 | Thalidomide-O-PEG2-propargyl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 60477-38-5 | Pifithrin-α,p-Nitro,Cyclic |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 3616-04-4 | Phosphorylcholine |
≥98% | | 询价 |
| 4 | 188532-26-5 | NL-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | | Targaprimir-96 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 1655508-14-7 | Targaprimir-96 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 218136-59-5 | SC-26196 HCl |
≥98% | | 询价 |
| 8 | 39111-07-4 | Nigranoic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 2259318-46-0 | SC-VC-PAB-MMAE |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 1055411-77-2 | Dopamine D2 receptor antagonist-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 2156-29-8 | 2-Di-1-ASP |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | | Adrenomedullin(AM)(22-52),human TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 15982-84-0 | (E/Z)-BCI |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | | MMP-9-IN-1 |
≥98% | | 询价 |
| 15 | 688342-78-1 | D-I03 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 22139-77-1 | Pinosylvin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 864756-35-4 | TC-MCH 7c |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 210344-97-1 | Z-YVAD-FMK |
≥98% | | 询价 |
| 19 | | DB04760 analog 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 63223-86-9 | Ginsenoside Rh1 |
≥98% | | 询价 |
| 21 | 942063-86-7 | JHU-75528 C-11 |
≥98% | | 询价 |
| 22 | 444659-43-2 | SCH-351591 |
≥98% | | 询价 |
| 23 | 290296-68-3 | Befetupitant |
≥98% | | 询价 |
| 24 | 2437-23-2 | Ammonium laurate |
≥98% | | 询价 |
| 25 | 620-40-6 | Tribenzylamine |
≥98% | | 询价 |
| 26 | 151489-04-2 | S 16317 |
≥98% | | 询价 |
| 27 | 148077-11-6 | Appenolide B |
≥98% | | 询价 |
| 28 | | SW15 |
≥98% | | 询价 |
| 29 | 256411-32-2 | Belotecan free base |
≥98% | | 询价 |
| 30 | 193611-67-5 | SB 216641 HCl |
≥98% | | 询价 |
| 31 | 84071-15-8 | Ramixotidine |
≥98% | | 询价 |
| 32 | 1312309-63-9 | Azido-PEG2-acid |
≥98% | | 询价 |
| 33 | 1422343-76-7 | GS-7339 monofumarate |
≥98% | | 询价 |
| 34 | 70974-81-1 | WB 4291 |
≥98% | | 询价 |
| 35 | 1260248-03-0 | AZ3971 |
≥98% | | 询价 |
| 36 | 21034-17-3 | Quaternium-45 |
≥98% | | 询价 |
| 37 | 62824-38-8 | Blennin C |
≥98% | | 询价 |
| 38 | 216685-07-3 | AR-C117977 |
≥98% | | 询价 |
| 39 | 40498-13-3 | Leucoquinizarin |
≥98% | | 询价 |
| 40 | 4849-90-5 | Aristolochic acid C |
≥98% | | 询价 |
| 41 | 64-85-7 | Desoxycortone |
≥98% | | 询价 |
| 42 | 1301178-83-5 | BAK2-66 |
≥98% | | 询价 |
| 43 | 1957276-35-5 | SHP836 |
≥98% | | 询价 |
| 44 | 1359752-95-6 | (3R,4R)-A2-32-01 |
≥98% | | 询价 |
| 45 | 1062444-54-5 | 1V209 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 2064175-41-1 | FKBP12 PROTAC dTAG-13 |
≥98% | | 询价 |
| 47 | 1173023-36-3 | L-745870 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 2378258-52-5 | PROTAC K-Ras Degrader-1 |
≥98% | | 询价 |
| 49 | | K-Ras ligand-Linker Conjugate 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | | K-Ras ligand-Linker Conjugate 2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | | (S)-GNE-987 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | | GNE-987 |
≥98% | | 询价 |
| 53 | 1781934-50-6 | AR-C102222 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | | Vitexin arginine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 2222981-71-5 | MAC glucuronide linker-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1043854-13-2 | J14 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 151533-34-5 | (Rac)-Acolbifene |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 207390-14-5 | 3-Bromocytisine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | | α2β1 Integrin Ligand Peptide TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 2259318-55-1 | DBCO-(PEG2-VC-PAB-MMAE)2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com